NIH-funded research R21 grant

Rapid protein deletion in brain neurons

Official title: Development of a Rapid Protein Deletion Platform for central nervous system neurons

Funded at Texas A&m Agrilife Research · NIH-11456646 · Data updated 2026-11-12

A new tool aims to quickly remove specific proteins from adult brain neurons to study how they work and to help respond to acute brain injuries.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas A&m Agrilife Research
NIH-funded
Lab location1 site (College Station, UNITED STATES)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$432,061
NIH project number1R21EY039508-01
Project IDNIH-11456646 on NIH RePORTER

Who could benefit from this research

Could help

Adults with conditions affecting CNS neurons could potentially benefit from future applications or trials using this technology.

Less likely to help

This early-stage technology is focused on tool development and may not directly benefit patients in the short term.

What this research studies

This project will create a fast, reversible method to delete chosen proteins in adult CNS neurons using engineered protein degraders that trigger the cell’s proteasome system. The degraders are delivered into neurons with specialized peptides that allow them to work inside the brain safely. Researchers will test whether this approach can remove target proteins in less than an hour, enabling study of dynamic neural processes. If successful, the platform could be used to explore how proteins control neuron function and may have translational potential for acute neurological events like traumatic injury.

Why it matters

Potential benefit: If successful, patients could benefit from new ways to study and possibly treat acute brain injuries by rapidly modulating protein activity in neurons.

How similar studies have gone: Similar protein-degradation strategies have shown promise in cells and model systems, but translating to CNS neurons is an area of active research.

Where this research is happening

  • Texas A&m Agrilife Research
    College Station, United States
    Active

Researchers

  • Principal investigator: Pellois, Jean-Philippe — Texas A&m Agrilife Research
  • Study coordinator: Pellois, Jean-Philippe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.